Year: 2020

news_6

GNT Pharma Announces Positive Top-Line Results in a Phase II Study of Nelonemdaz for Acute Ischemic Stroke Patients Treated With Endovascular Thrombectomy

Safety and Tolerability Established Good and Excellent Functional Outcome Increased YONGIN, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--GNT Pharma Inc. today reports positive top-line...